BlackRock Institutional Trust’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $69.1M | Buy |
2,397,396
+86,715
| +4% | +$2.5M | 0.01% | 1139 |
|
|
2016
Q3 | $73.5M | Buy |
2,310,681
+116,594
| +5% | +$3.71M | 0.01% | 1053 |
|
|
2016
Q2 | $71.2M | Buy |
2,194,087
+101,128
| +5% | +$3.28M | 0.01% | 1034 |
|
|
2016
Q1 | $58.5M | Buy |
2,092,959
+114,358
| +6% | +$3.2M | 0.01% | 1123 |
|
|
2015
Q4 | $70.5M | Buy |
1,978,601
+86,501
| +5% | +$3.08M | 0.01% | 1033 |
|
|
2015
Q3 | $62.6M | Sell |
1,892,100
-69,342
| -4% | -$2.29M | 0.01% | 1110 |
|
|
2015
Q2 | $82.1M | Sell |
1,961,442
-462,936
| -19% | -$19.4M | 0.01% | 1016 |
|
|
2015
Q1 | $79M | Buy |
2,424,378
+363,768
| +18% | +$11.9M | 0.01% | 1060 |
|
|
2014
Q4 | $65.4M | Sell |
2,060,610
-57,578
| -3% | -$1.83M | 0.01% | 1117 |
|
|
2014
Q3 | $52.4M | Sell |
2,118,188
-126,020
| -6% | -$3.12M | 0.01% | 1221 |
|
|
2014
Q2 | $50.7M | Buy |
2,244,208
+19,033
| +0.9% | +$430K | 0.01% | 1314 |
|
|
2014
Q1 | $54.1M | Buy |
2,225,175
+193,854
| +10% | +$4.72M | 0.01% | 1226 |
|
|
2013
Q4 | $50.8M | Buy |
2,031,321
+33,997
| +2% | +$850K | 0.01% | 1241 |
|
|
2013
Q3 | $54.9M | Buy |
1,997,324
+80,860
| +4% | +$2.22M | 0.01% | 1141 |
|
|
2013
Q2 | $34.8M | Buy |
+1,916,464
| New | +$34.8M | 0.01% | 1391 |
|